Yiqi Huoxue Huatan Granule for Reducing Mortality in COPD With Chronic Respiratory Failure
Status:
Enrolling by invitation
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This study aims to establish the treatment scheme of Yiqi Huoxue Huatan granule for chronic
obstructive pulmonary disease (COPD) with chronic respiratory failure (CRF), reducing
mortality, improving quality of life and forming high quality evidence.
Phase:
Phase 3
Details
Lead Sponsor:
Peking University People's Hospital
Collaborator:
The Affiliated Hospital of Liaoning University of TCM